Neuroone Medical Technologies (NMTC) Profit After Tax Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.72% |
| Dec 31, 2025 | 6.00% |
| Sep 30, 2025 | -23.38% |
| Jun 30, 2025 | 26.70% |
| Mar 31, 2025 | -11.03% |
| Dec 31, 2024 | 18.99% |
| Sep 30, 2024 | -19.88% |
| Jun 30, 2024 | -8.24% |
| Mar 31, 2024 | -5.24% |
| Jun 30, 2023 | -22.43% |
| Mar 31, 2023 | -21.03% |
| Dec 31, 2022 | -1.29% |
| Sep 30, 2022 | -7.79% |
| Jun 30, 2022 | -16.35% |
| Mar 31, 2022 | -33.19% |
| Dec 31, 2021 | -60.16% |
| Sep 30, 2021 | -193.02% |
| Jun 30, 2021 | -191.15% |
| Mar 31, 2021 | -205.75% |
| Dec 31, 2020 | -152.56% |
| Sep 30, 2020 | -123.90% |
| Jun 30, 2020 | -217.02% |
| Mar 31, 2020 | -158.83% |
| Jun 30, 2019 | -158.89% |
| Mar 31, 2019 | -249.72% |
| Jun 30, 2018 | -131.12% |
| Mar 31, 2018 | -233.11% |
| Dec 31, 2017 | -308.72% |
| Sep 30, 2017 | -187.84% |
| Jun 30, 2017 | -253.31% |
| Mar 31, 2017 | -165.08% |
| Dec 31, 2016 | -76.58% |
| Sep 30, 2016 | -23.97% |
| Jun 30, 2016 | -64.20% |
| Mar 31, 2016 | -6.01% |
| Dec 31, 2015 | -103.46% |
| Sep 30, 2015 | -14.13% |